Prospective evaluation of a new anti-ulcer agent, ecabet sodium, for the treatment of Helicobacter pylori infection.

BACKGROUND A new anti-ulcer agent, ecabet sodium, is active against Helicobacter pylori. AIM To assess the efficacy of ecabet sodium for the eradication of H. pylori in patients with gastroduodenal diseases. METHODS In a prospective, randomized and controlled study, patients infected with H. pylori were assigned to one of the following two groups: group… CONTINUE READING